Etizolam

Etizolam

SCHEMBL10869413

CCc1cc2c(s1)-n1c(C)nnc1CN=C2c1ccccc1Cl.O=C(O)O

nearest known ligand 0.90

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Etizolam. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 1/20 0.90
PDE4D Q08499 1/20 0.90
PTAFR P25105 19/20 0.68
CYP3A4 P08684 1/20 0.68
ALOX15 P16050 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Etizolam SCHEMBL30665015 0.95 OPRK1 (1.00) OPRK1PDE4DPTAFRCYP3A4ALOX15
Etizolam SCHEMBL42920 0.95 OPRK1 (1.00) OPRK1PDE4DPTAFRCYP3A4ALOX15
SCHEMBL9654335 0.90 OPRK1 (0.76) OPRK1PDE4DPTAFRCYP3A4ALOX15
Etizolam SCHEMBL28086661 0.90 OPRK1 (0.85) OPRK1PDE4DPTAFRCYP3A4ALOX15
SCHEMBL8928418 0.89 PTAFR (0.77) OPRK1PDE4DPTAFRCYP3A4ALOX15
Bicarbonate SCHEMBL10510835 0.88 PTAFR (0.72) OPRK1PDE4DPTAFRCYP3A4ALOX15
SCHEMBL8928483 0.87 OPRK1 (0.84) OPRK1PDE4DPTAFRCYP3A4ALOX15
SCHEMBL9662085 0.87 PTAFR (0.72) OPRK1PDE4DPTAFRCYP3A4ALOX15
SCHEMBL8928481 0.87 OPRK1 (0.84) OPRK1PDE4DPTAFRCYP3A4ALOX15
SCHEMBL9542386 0.86 OPRK1 (0.70) OPRK1PDE4DPTAFRCYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0194416-A1 Thieno-triazolo-1,4-diazepino-2-carboxamides, process for their preparation and pharmaceutical compositions BOEHRINGER INGELHEIM KG (DE) 1986-09-17 EP disclosed